French drug company stockpiling medicines in preparation for Brexit

French drug maker Sanofi is increasing its stocks by four weeks in order to stockpile a 14 week supply of medicines in the event of a disruption to supply caused by a hard Brexit.

Additional supplies of a wide range of products, such as insulin, are being built up.

Hugo Fry, Sanofi UK’s managing director, said “The uncertainty in the Brexit negotiations means that Sanofi has been planning for a ‘no deal’ scenario.

“Patient safety is our main priority and we have made arrangements for additional warehouse capacity in order to stockpile our products, where global supply allows, in the UK and increase UK-based resource to prepare for any changes to customs or regulatory processes.”

In addition to this, Health Secretary Matt Hancock has recently announced that the NHS in England was preparing to stockpile medicines and blood in the event that the UK leaves the EU without a deal. He told the Health Select Committee that he had requested that the department consider options for stockpiling by industry.

He went on to say “We are working with industry for the potential need for stockpiling in the event of a no-deal Brexit.”

Chadwick Lawrence’s specialist team of clinical negligence lawyers have years of experience in medical negligence compensation claims, and have obtained substantial compensation for our clients. Not only do we represent clients in Yorkshire, but because of our reputation we also represent clients nationally.

If you believe that you or a relative may have been injured as a result of clinical/medical negligence, please call for free legal advice from our medical negligence solicitors on the freephone number below.

Posted by Tony May, Partner/head of Clinical Negligence Department, Chadwick Lawrence LLP (tonymay@chadlaw.co.uk ), medical negligence lawyers and clinical negligence solicitors in Huddersfield, Leeds, Wakefield and Halifax, West Yorkshire.

Freephone : 0800 304 738